195 related articles for article (PubMed ID: 35244154)
1. A dog model for centronuclear myopathy carrying the most common DNM2 mutation.
Böhm J; Barthélémy I; Landwerlin C; Blanchard-Gutton N; Relaix F; Blot S; Laporte J; Tiret L
Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35244154
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness.
Cowling BS; Toussaint A; Amoasii L; Koebel P; Ferry A; Davignon L; Nishino I; Mandel JL; Laporte J
Am J Pathol; 2011 May; 178(5):2224-35. PubMed ID: 21514436
[TBL] [Abstract][Full Text] [Related]
3. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
[TBL] [Abstract][Full Text] [Related]
4. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.
Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S
J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624
[TBL] [Abstract][Full Text] [Related]
5. Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.
Liewluck T; Lovell TL; Bite AV; Engel AG
Neuromuscul Disord; 2010 Dec; 20(12):801-4. PubMed ID: 20817456
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2.
Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I
Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877
[TBL] [Abstract][Full Text] [Related]
7. DNM2 mutations in Chinese Han patients with centronuclear myopathy.
Lin P; Liu X; Zhao D; Dai T; Wu H; Gong Y; Yan C
Neurol Sci; 2016 Jun; 37(6):995-8. PubMed ID: 26908122
[TBL] [Abstract][Full Text] [Related]
8. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy.
Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS
Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461
[TBL] [Abstract][Full Text] [Related]
9. Reducing dynamin 2 (DNM2) rescues
Buono S; Ross JA; Tasfaout H; Levy Y; Kretz C; Tayefeh L; Matson J; Guo S; Kessler P; Monia BP; Bitoun M; Ochala J; Laporte J; Cowling BS
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11066-11071. PubMed ID: 30291191
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.
Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB
Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
[TBL] [Abstract][Full Text] [Related]
12. Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.
Cowling BS; Chevremont T; Prokic I; Kretz C; Ferry A; Coirault C; Koutsopoulos O; Laugel V; Romero NB; Laporte J
J Clin Invest; 2014 Mar; 124(3):1350-63. PubMed ID: 24569376
[TBL] [Abstract][Full Text] [Related]
13. Mutational and clinical spectrum of centronuclear myopathy in 9 cases and a literature review of Chinese patients.
Wang Q; Yu M; Xie Z; Liu J; Wang Q; Lv H; Zhang W; Yuan Y; Wang Z
Neurol Sci; 2022 Apr; 43(4):2803-2811. PubMed ID: 34595679
[TBL] [Abstract][Full Text] [Related]
14. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model.
Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M
Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559
[TBL] [Abstract][Full Text] [Related]
15. Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China.
Chen T; Pu C; Wang Q; Liu J; Mao Y; Shi Q
Neurol Sci; 2015 May; 36(5):735-41. PubMed ID: 25501959
[TBL] [Abstract][Full Text] [Related]
16. Adult centronuclear myopathies: A hospital-based study.
Echaniz-Laguna A; Biancalana V; Böhm J; Tranchant C; Mandel JL; Laporte J
Rev Neurol (Paris); 2013; 169(8-9):625-31. PubMed ID: 23938035
[TBL] [Abstract][Full Text] [Related]
17. Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.
Zhao Y; Zhao Z; Shen H; Bing Q; Hu J
Neurol Sci; 2018 Dec; 39(12):2043-2051. PubMed ID: 30232666
[TBL] [Abstract][Full Text] [Related]
18. [The dynamin-2-gene related centronuclear myopathy].
Bitoun M
Med Sci (Paris); 2023 Nov; 39 Hors série n° 1():6-10. PubMed ID: 37975763
[TBL] [Abstract][Full Text] [Related]
19. Imaging-based evaluation of pathogenicity by novel DNM2 variants associated with centronuclear myopathy.
Fujise K; Okubo M; Abe T; Yamada H; Takei K; Nishino I; Takeda T; Noguchi S
Hum Mutat; 2022 Feb; 43(2):169-179. PubMed ID: 34837441
[TBL] [Abstract][Full Text] [Related]
20. MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy.
Giraud Q; Spiegelhalter C; Messaddeq N; Laporte J
Brain; 2023 Oct; 146(10):4158-4173. PubMed ID: 37490306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]